Managing esophageal fistulas in advanced esophageal cancer
Part of Cancer, Digestive system clinical trials.
This trial tests a standardized way of managing a new complication of esophageal cancer called an esophageal fistula, which is a hole or leak in the esophagus. The goal is to prevent infections and improve quality of life, and the treatment may combine medications with procedures to close the leak.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 75 years old.
- Have a confirmed diagnosis of esophageal squamous cell carcinoma (a type of esophageal cancer).
- Have advanced cancer that cannot be removed with surgery.
- Have a newly diagnosed esophageal fistula (a hole or leak in the esophagus, which is the food tube).
- Received no more than 3 prior cancer treatments (such as chemotherapy or immunotherapy).
- Be generally healthy enough for minor procedures, with adequate blood counts and organ function.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks changes in your tumor over time using advanced tests on blood and tissue samples. The goal is to better understand your cancer and help guide treatment for you and future patients.
This trial tests whether combining a new immunotherapy drug (adebrelimab) with standard chemotherapy can help shrink borderline resectable esophageal squamous cell carcinoma before surgery. The goal is to make tumors easier to remove and improve survival.
This trial tests whether adding two immunotherapy drugs to standard chemotherapy and radiation before surgery can help shrink esophageal cancer and improve outcomes. It is for people with a certain type of esophageal cancer that can be removed with surgery.
This trial tests different combinations of treatments given before surgery for a type of esophageal cancer called squamous cell carcinoma. It aims to find the best approach to shrink the tumor and improve outcomes for patients whose cancer has not spread to distant organs.
This trial tests a combination of three medicines (immunotherapy plus two chemotherapy drugs) given before surgery to shrink esophageal cancer. The goal is to make the tumor smaller and easier to remove completely, potentially improving the chance of a cure.
This trial tests whether a personalized treatment plan, chosen using a lab-grown model of your tumor, works better than standard therapy for esophageal cancer that can be surgically removed. It aims to find the most effective drugs for you before surgery.
Hear when a new Esophageal Squamous Cell Carcinoma (ESCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.